Tudor Investment Corp
COLL icon

Tudor Investment Corp’s Collegium Pharmaceutical COLL Stock Holding History

Tudor Investment Corp’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$462K Sell
13,956
-3,220
-19% -$136K ﹤0.01% 2873
2025
Q4 		$795K Buy
17,176
+1,166
+7% +$48.8K ﹤0.01% 2434
2025
Q3 		$560K Buy
+16,010
New +$557K ﹤0.01% 2634
2017
Q2 		– Sell
-15,000
Closed -$151K – 1076
2017
Q1 		$151K Buy
+15,000
New +$223K ﹤0.01% 1268

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Tudor Investment Corp's COLL Position: Q1 2026 in Review

Tudor Investment Corp reduced its Collegium Pharmaceutical (COLL) stake by 19% in Q1 2026, selling an estimated $136K and leaving 13,956 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #2873.

Tudor Investment Corp first reported a position in COLL in Q1 2017 and has held it in 4 quarters since. The position peaked at $795K in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Tudor Investment Corp held 13,956 shares of Collegium Pharmaceutical worth $462K as of Q1 2026.
  • Tudor Investment Corp sold 3,220 Collegium Pharmaceutical shares in Q1 2026, an estimated $136K.
  • Collegium Pharmaceutical made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2873 holding.
  • Tudor Investment Corp first reported a position in Collegium Pharmaceutical in Q1 2017 and has held it in 4 quarters since.
  • Tudor Investment Corp's Collegium Pharmaceutical position peaked at $795K in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.